Araz Marachelian

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

Steven G. DuBois, Araz Marachelian, Elizabeth Fox et al. · Journal of Clinical Oncology · 2016 · 132 citations

Medicine, Oncology, Pharmacology +12

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children’s Oncology Group Study ANBL0531

Clare J. Twist, Mary Lou Schmidt, Arlene Naranjo et al. · Journal of Clinical Oncology · 2019 · 128 citations · Full text

Medicine, Oncology, Pediatrics +16

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser et al. · Nature Medicine · 2023 · 125 citations · Full text

Medicine, Oncology, Pharmacology +10

Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation

Soumen Khatua, Girish Dhall, Sharon O’Neil et al. · Pediatric Blood & Cancer · 2010 · 120 citations

Medicine, Oncology, Radiation Oncology +14

Predictors of outcome in children with Langerhans cell histiocytosis

Rima Jubran, Araz Marachelian, Frederick J. Dorey et al. · Pediatric Blood & Cancer · 2005 · 102 citations

Medicine, Endocrinology, Pediatrics +7